Intra Cellular Therapies | Kostnadene For Salg

Cost Of Sales Endring Dato
Acadia Pharmaceuticals USD 17.89M 3.27M 2023-12
ALKERMES USD 61.51M 1.75M 2023-09
Bristol-Myers Squibb USD 2.71B 217M 2023-12
Gilead Sciences USD 1.61B 46M 2023-12
Halozyme Therapeutics USD 52.3M 2.52M 2023-12
Intra Cellular Therapies USD 10.7M 1.57M 2023-12
Neurocrine Biosciences USD 11.2M 300K 2023-09
RedHill Biopharma USD 806K 806K 2023-06
Supernus Pharmaceuticals USD 19.63M 26K 2023-12
United Therapeutics USD 71M 900K 2023-12



Intra Cellular Therapies Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.